clinical trials bpc-157 in humans If worked as well as the internet says it does… …we'd probably have high quality human by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of BPC-157 – No Proof Required!
Description
A phase 3 study (NCT04822181), which enrolled 1200 patients with biopsy-proven MASH and fibrosis, is currently ongoing to assess the benefit of OW subcutaneous semaglutide 2 mg in this setting 93
Megaloblastic Anemia
Duration varies based on your baseline level, diet, sleep, stress, and schedule
Scientists isolated and synthesized the active peptide fragment, BPC-157, and discovered that it retained and amplified many of the original compounds healing benefitsextending far beyond the gastrointestinal system
I was not sure if i would overcome the symptoms
Monitoring: Monitor for adverse reactions
